VERAXA Biotech AG
VRXANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $19.98M
- P/E (TTM)
- 2.97
- Forward P/E
- 3.84
- Dividend yield
- -
- 52-week range
- $0.99$27.36
- Volume (live)
- -
- Avg. volume (3M)
- 207.62K
VERAXA Biotech (VRXA) Stock Price & Financial Analysis
VERAXA Biotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.99 - $1.06 |
|---|---|
| 52-Week High | $27.36 |
| 52-Week Low | $0.99 |
| Open | $1.04 |
| Volume (last close) | 137.87K |
| Average Volume (3M) | 207.62K |
| 50-Day MA | $1.46 |
|---|---|
| 200-Day MA | $7.35 |
| 1-Year Change | −90.17% |
| Market Cap | 19.98M |
|---|---|
| Shares Outstanding | 19.98M |
| P/E Ratio (TTM) | 2.97 |
| Forward P/E | 3.84 |
| Price to Book (P/B) | -1.38 |
| EV/EBITDA | -5.53 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
VERAXA Biotech at a Glance
As of the Oct 23, 2026 close, VERAXA Biotech (VRXA) has a market capitalization of $19.98M. The stock trades at 3.0× trailing earnings and 3.8× forward earnings.
As of its latest reported balance sheet, it holds $32.79K in cash and securities against $0.00 of debt, a net cash position of $32.79K.
VERAXA Biotech does not currently pay a dividend.
The share price is down 90.2% over the past year. At $1.00 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.99 to $27.36, below its 200-day moving average of $7.35.
Frequently Asked Questions About VERAXA Biotech
What is the current stock price for VRXA?
As of the Oct 23, 2026 close, VRXA stock trades at $1.00. The 52-week range is $0.99–$27.36, with a day range of $0.99–$1.06.
What is the P/E ratio for VRXA?
As of the Oct 23, 2026 close, VERAXA Biotech's trailing twelve-month (TTM) P/E ratio is 3.0, meaning investors pay $3.0 for every $1 of annual earnings. The forward P/E is 3.8, reflecting analyst expectations for future earnings. VERAXA Biotech operates in the Healthcare sector.
Does VRXA pay dividends?
VERAXA Biotech does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for VRXA?
Analyst ratings and recommendations for VRXA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of VRXA?
As of the Oct 23, 2026 close, VERAXA Biotech's market capitalization is $20.0M, classifying it as a micro-cap company. VERAXA Biotech operates in the Healthcare sector within the Biotechnology industry.